Patent EP0808606A1 successfully refreshed from Google Patents.
← Back to Patent Explorer
US5693513A Expired / Lapsed US ⏱️ 0.0 years remaining

Encapsulation of living tissue cells in an organosilicon

Assignee: SOLGENE THERAPEUTICS LLC
•
Filing: 1995-11-08
•
Granted: 1997-12-02
•
Expires: 2015-11-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Living tissue cells such as animal or plant tissue cell are encapsulated in an inorganic gel by mixing an organosilicon precursor with an aqueous acidic solution to form a gel forming solution and hydrolyze the organosilicon precursor, cooling the gel forming solution, forming a mixture of living tissue cells and Hank's balanced salt solution, adding a base solution to the gel forming solution to form a mixture, immediately thereafter adding the mixture containing living tissue cells to the mixture containing the gel forming solution, and pouring the resultant mixture into a container where an inorganic gel forms encapsulating the cells. The organosilicon precursor may be tetraethoxysilane, tetrabutoxysilane, tetramethoxysilane or tetrapropoxysilane.

Inventors

  • 👤 Edward J. A. Pope

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 06:39
CPC Classifications
A; A61; A61K; A61K47/00; A61K47/02; C; C03; C03C; C03C4/00; C03C4/0007; C12; C12N; C12N11/00; C12N11/02; C12N11/04

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 250 words
A process for encapsulating living tissue cells in an inorganic gel comprising the steps of: a. mixing an organosilicon precursor and an acidic solution which is highly aqueous having a molar concentration of acid in the range of 0.05 to 2.5 to form a gel forming solution wherein said organosilicon precursor is selected from a group consisting of tetraethoxysilane, tetrabutoxysilane, tetramethoxysilane and tetrapropoxysilane; b. stirring said gel forming solution until said gel forming solution becomes clear whereby water in said highly aqueous acidic solution hydrolyzes said organosilicon precursor; c. chilling said gel forming solution in an ice bath; d. mixing living tissue cells and Hank's balanced salt solution to form a mixture of tissue cells and Hank's balanced salt solution; e. adding a base solution having a molar concentration of base in the range of 0.05 to 2.5 to said gel forming solution to form a mixture of said gel forming solution and said base solution; f. immediately thereafter adding said mixture of tissue cells and Hank's balanced salt solution to said mixture of said gel forming solution and said base solution and stirring to form a mixture of said gel forming solution and said base solution with said mixture of said tissue cells and Hank's balanced salt solution; and g. pouring into a container said mixture of said mixture of said gel forming solution and said base solution with said mixture of tissue cells and Hank's balanced salt solution to form an inorganic gel encapsulating said living tissue cells.
Claim 2
Dependent Claim 250 words
A process for encapsulating living tissue cells in an inorganic gel comprising the steps of: a. mixing an organosilicon precursor and an acidic solution which is highly aqueous having a molar concentration of acid in the range of 0.05 to 2.5 to form a gel forming solution wherein said organosilicon precursor is selected from a group consisting of tetraethoxysilane, tetrabutoxysilane, tetramethoxysilane and tetrapropoxysilane; b. stirring said gel forming solution until said gel forming solution becomes clear whereby water in said highly aqueous acidic solution hydrolyzes said organosilicon precursor; c. chilling said gel forming solution in an ice bath; d. mixing living tissue cells and Hank's balanced salt solution to form a mixture of tissue cells and Hank's balanced salt solution; e. adding a base solution having a molar concentration of base in the range of 0.05 to 2.5 to said gel forming solution to form a mixture of said gel forming solution and said base solution; f. immediately thereafter adding said mixture of tissue cells and Hank's balanced salt solution to said mixture of said gel forming solution and said base solution and stirring to form a mixture of said gel forming solution and said base solution with said mixture of said tissue cells and Hank's balanced salt solution; and g. pouring into a container said mixture of said mixture of said gel forming solution and said base solution with said mixture of tissue cells and Hank's balanced salt solution to form an inorganic gel encapsulating said living tissue cells.

References Cited (Backward Citations)

US4148689A Cited
US4391909A Cited
US4797213A Cited
US5200334A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2000-12-01 2001-06-02 2001-12-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2004-12-01 2005-06-02 2005-12-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2008-12-01 2009-06-02 2009-12-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag